Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024433
Filing Date
2024-10-02
Accepted
2024-10-02 16:41:45
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form4-10022024_081040.html 4  
1 form4-10022024_081040.xml 4 4031
  Complete submission text file 0001415889-24-024433.txt   5553
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address TWO COMMERCE SQUARE, 2001 MARKET STREET 28TH FLOOR PHILADELPHIA PA 19103
Business Address
Cale Edgar B. (Reporting) CIK: 0001799783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 241348216